DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Barnum CJ, Chen X, Chung J. et al.
Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro®1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats.
J Parkinsons Dis 2014;
4 (03) 349-360
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.